Unveiling Biomarkers of Telitacicept’s Efficacy in SLE Treatment Through Proteomics

ABSTRACT: Our study is highly relevant to the fields of Medical Bioinformatics and Personalised Medicine, as it employs high-throughput omics technologies and bioinformatics analyses to uncover personalized biomarkers predictive of treatment response, thereby paving the way for tailored therapeutic strategies in SLE management. By proteomic datasets, we provide a comprehensive view of the molecular alterations associated with Telitacicept treatment, offering novel insights into the pathogenesis of SLE and the mechanisms of action of this promising biologic agent.

ORGANISM(S): Homo Sapiens

SUBMITTER: Fen Li  

PROVIDER: PXD073923 | iProX | Mon Feb 02 00:00:00 GMT 2026

REPOSITORIES: iProX